Evaluate the Effects of Citicoline on Cognitive Performance in Healthy Adults
← catalyst calendarSponsored by Kirin Holdings Company, Limited (industry) · 2503.T — their whole pipeline →. With Nutrasource Pharmaceutical and Nutraceutical Services, Inc..
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · Triple · Health services research
Enrollment
90actual
Sites
1
Country
Canada
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-11-20 | actual | When the study began enrolling |
| Primary completion | 2025-05-31 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-06-20 | actual | The whole study's end, after follow-up |
| First posted | 2025-04-02 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-07-09 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Healthy
- Cognitive Performance
Interventions
- Dietary supplement: Placebo
- Dietary supplement: Cognizin® — also filed as Citicoline supplement
Primary outcome
what the primary-completion date above is the date OFTo evaluate the effect of the Test Product (TP) on cognitive performance compared to a placebo after 12 weeks using the Psychomotor Vigilance Test (PVT)
measured 12 weeks
Permalink · 2503.T's whole pipeline · Catalyst calendar · Every registered study · What changed